Markus M. Heimesaat, MD

Charité University Hospital, Department of Microbiology and Hygiene
Berlin Germany Papers:
T.90 Targeting human CD2 by the monoclonal Antibody CB.219 reduces intestinal Inflammation in a humanized Transfer Colitis Model
W.31 Molecular regulation of T helper cell self-control